Delivery Order SPE2DB20D3103-SPE2DB22FL7K9
- Not listed
- This federal contract award, valued at $81,649.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Cencora, Inc. pharmaceutical distribution company. The contract is for the delivery of TWINRIX vaccine syringes, a hepatitis A and B combination vaccine, to support military healthcare programs. The award is a delivery order placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award, valued at $1,400.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine, to support military treatment facilities and other government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up...
- This federal contract award, valued at $48,051.00, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,293.61 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award, valued at $182,299.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Twinrix vaccine syringes, a hepatitis A and hepatitis B combination vaccine, to support military and federal healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 6, 2022. Amerisourcebergen, a major pharmaceutical distributor, holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide the Twinrix vaccine in syringe form. The contract has a ceiling value of $4,196.98 and a completion date of July 26, 2023. It is a firm-fixed-price delivery order contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through November 2026....
- This federal contract award, valued at $3,933.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a combination hepatitis A and hepatitis B vaccine, to support various federal government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,050.60 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, a vaccine product. The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award, valued at $5,249.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a vaccine product. It is a firm fixed-price delivery order contract with a completion date of February 5, 2024. The contract was awarded on February 3, 2024 and has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award, valued at $3,472.45, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and B vaccine, with a completion date of May 4, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FL7K9Delivery Order
This federal contract award is a delivery order, valued at $54,432.96, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine, with an ultimate completion date of November 23, 2021. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC with the DLA Troop Support Medical is a significant contract that enables efficient government procurement of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical care materials. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $54.4k | 11/22/21 |